CD44 and cancer: Similarly, in vivo studies using zebrafish cancer cell xenograft models showed that the glycoprotein CD44 and the integrins αvβ3 and α5β1 are required for weak (CD44 and αvβ3) and strong (α5β1) interactions between CTCs and endothelial cells (Osmani et al., 2019).